Improvement in Oral Chronic Graft-versus-Host Disease with the Administration of Effervescent Tablets of Topical Budesonide-An Open, Randomized, Multicenter Study

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 1, 2012, Pages 134-140

  Elad, Sharon ^a   Zeevi, Itai ^a   Finke, Jürgen ^b   Koldehoff, Michael ^c   Schwerdtfeger, Rainer ^d   Wolff, Daniel ^e   Mohrbacher, Ralf ^f   Levitt, Michael ^a   Greinwald, Roland ^f   Shapira, Michael Y ^g  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d DKD   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f Dr Falk Pharma GmbH   (Germany)

^g HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Budesonide; Chronic; Graft versus host disease; Mucosa; Oral; Steroid; Topical

Indexed keywords

BECLOMETASONE; BUDESONIDE; DEXAMETHASONE; MOUTHWASH;

ADULT; ARTICLE; CHEILITIS; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EFFERVESCENT TABLET; ESOPHAGITIS; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERKERATOSIS; MAJOR CLINICAL STUDY; MALE; MOUTH LESION; MULTICENTER STUDY; MYCOSIS; OPEN STUDY; PHASE 4 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADULT; BUDESONIDE; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; PILOT PROJECTS; TABLETS;

EID: 84855423832     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.06.001     Document Type: Article

References (22)

1. Lee S.J., Flowers M.E. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2008, 134-141.
2. Epstein J.B., Raber-Drulacher J.E., Wilkins A., Chavarria M.G., Myint H. Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:301-312.
3. Woo S.B., Lee S.J., Schubert M.M. Graft-vs.-host disease. Crit Rev Oral Biol Med 1997, 8:201-216.
4. Schubert M.M., Correa M.E. Oral graft-versus-host disease. Dent Clin North Am 2008, 52:79-109. viii-ix.
5. Imanguli M.M., Pavletic S.Z., Guadagnini J.P., Brahim J.S., Atkinson J.C. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101:175-183.
6. Meier J.K., Wolff D., Pavletic S., et al. Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig 2011, 15:127-139.
7. Couriel D., Carpenter P.A., Cutler C., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006, 12:375-396.
8. U.S. National Institutes of Health. Available from: . Accessed July 15, 2011. http://clinicaltrials.gov/ct2/results?term=oral+GVHD.
9. Andree H., Hilgendorf I., Leithaeuser M., et al. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD. Bone Marrow Transplant 2008, 42:541-546.
10. Elad S., Or R., Garfunkel A.A., Shapira M.Y. Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 95:308-311.
11. Dilger K., Halter J., Bertz H., Lopez-Lazaro L., Gratwohl A., Finke J. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2009, 15:336-343.
12. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
13. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981, 47:207-214.
14. Sonis S.T., Eilers J.P., Epstein J.B., et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999, 85:2103-2113.
15. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006, 12:252-266.
16. WHO. WHO's Pain Ladder. Geneva: WHO. Available at: ). Accessed July 14, 2011. http://www.who.int/cancer/palliative/painladder/en.
17. Ventafridda V., Tamburini M., Caraceni A., De Conno F., Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987, 59:850-856.
18. Schubert M.M., Williams B.E., Lloid M.E., Donaldson G., Chapko M.K. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992, 69:2469-2477.
19. Sari I., Altuntas F., Kocyigit I., et al. The effect of budesonide mouthwash on oral chronic graft versus host disease. Am J Hematol 2007, 82:349-356.
20. Utsman R.A., Epstein J.B., Elad S. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:e11-e17.
21. Thomson A.B., Sadowski D., Jenkins R., Wild G. Budesonide in the management of patients with Crohn's disease. Can J Gastroenterol 1997, 11:255-260.
22. Danielsson A. Treatment of distal ulcerative colitis with nonsystemic corticosteroid enemas. Scand J Gastroenterol 1996, 31:945-953.